FundedIQ
Pharmaceutical Manufacturing

Corsair Pharma

Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.

www.corsairpharma.com Sunnyvale, United States 1-10 employees
Total raised
$23.0M
Rounds
1
Latest
Series B
Sep 2023

Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.

Corsair Pharma has raised $23.0M across 1 round. Its most recent round was a Series B of $23.0M in Sep 2023. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Sep 20, 2023
Series B
$23.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Corsair Pharma is featured in

Similar companies

India Globalization Capital

India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and China. In India, the Company is engaged in supplying and trading iron ore and in leasing construction equipment, and to a lesser extent constructing roads, highways and supply rock aggregate. In June 2014, the Company acquired 51% interest of Golden Gate Electronics Limited.

$3.0M
Lenz Therapeutics

LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.

Series Unknown $49.0M
Egetis Therapeutics AB

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.

Series Unknown $26.7M
ThinkStream.ai

ThinkStream is an AI powered assistant transforming inbox chaos into focused, goal-driven workstreams.

Seed $20k
Vast

Vast develops commercial space stations and plans crewed missions with SpaceX, supporting research, production, and habitation.

Series A $150M
OmniSpeech

OmniSpeech™ is an innovative software technology company that aims to revolutionize the enhancement of voice quality in IP communications.

Pre-Seed $500k
Empathium

Empathium is an AI-powered emotional intelligence platform training human centered communication and care.

Seed $10k
Maritime Fusion

Maritime Fusion specializes in the development and construction of high-temperature superconducting fusion reactors.

Seed $4.5M
Verisoul

Verisoul is a company that designs a decentralized platform with artificial intelligence, aiming to aid businesses in combating the presence of fraudulent users. By merging anonymity and accountability, Verisoul collaborates with Web3 developers to enable them in identifying reliable users while distinguishing them from scammers, bots, and imposters.

Venture - Series Unknown $7.3M
Suma Wealth

SUMA is a revolutionary FinTech company with the mission to engage, educate, and empower the Latinx community via a holistic approach to Digital Media, Experiences, and FinTech. By creating culturally relevant content, and virtual experiences, and providing financial tools that demystify and reimagine financial wellness through entertainment.

Venture - Series Unknown $5.6M
Model ML

Model ML is an AI tool that improves workflows for investment banks and private equity firms by integrating multiple data sources for research and due diligence, with the goal of revolutionizing the finance industry with a more efficient AI workspace.

Series A $75.0M
The San Francisco Compute Company

The San Francisco Compute Company manufactures supercomputers.

Series A $40.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.